MAPT and Alzheimer disease: To further place the observed changes of tau and Aβ within the context of disease progression, the entire cohort (non-AD and AD cases) was subdivided based on the respective Braak stages (0-VI) and crude lysate measures of AT-8 phospho-tau and Aβ correlated with disease progression (Fig. 1c.i + ii).